The New Standard for Performance of Intracranial Angioplasty and Stent Placement after Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) Trial

References

1. 1.↵
   SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388–92. Epub 2004 Apr 22

   Abstract/FREE Full Text
2. 2.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Turan TN,
   4. et al

   . and SAMMPRIS Investigators. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis 2011;20:357–68. Epub 2011 Sep 7

   CrossRefPubMed
3. 3.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Derdeyn CP,
   4. et al

   . Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003. Epub 2011 Sep 7

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Zaidat OO,
   2. Klucznik R,
   3. Alexander MJ,
   4. et al

   . The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24. Epub 2008 Jan 30

   Abstract/FREE Full Text
5. 5.↵
   1. Fiorella D,
   2. Levy EI,
   3. Turk AS,
   4. et al

   . US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87

   Abstract/FREE Full Text
6. 6.↵
   1. Siddiq F,
   2. Vazquez G,
   3. Memon MZ,
   4. et al

   . Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008;39:2505–10

   Abstract/FREE Full Text